JP2007526248A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526248A5
JP2007526248A5 JP2006551541A JP2006551541A JP2007526248A5 JP 2007526248 A5 JP2007526248 A5 JP 2007526248A5 JP 2006551541 A JP2006551541 A JP 2006551541A JP 2006551541 A JP2006551541 A JP 2006551541A JP 2007526248 A5 JP2007526248 A5 JP 2007526248A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
polypeptide
amino acid
acid sequence
cell proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002996 external-priority patent/WO2005072419A2/en
Publication of JP2007526248A publication Critical patent/JP2007526248A/ja
Publication of JP2007526248A5 publication Critical patent/JP2007526248A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551541A 2004-01-27 2005-01-27 胃腸増殖因子およびその使用方法 Withdrawn JP2007526248A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53960504P 2004-01-27 2004-01-27
US60/539,605 2004-01-27
US61924104P 2004-10-15 2004-10-15
US60/619,241 2004-10-15
PCT/US2005/002996 WO2005072419A2 (en) 2004-01-27 2005-01-27 Gastrointestinal proliferative factor and uses thereof

Publications (2)

Publication Number Publication Date
JP2007526248A JP2007526248A (ja) 2007-09-13
JP2007526248A5 true JP2007526248A5 (enExample) 2009-03-05

Family

ID=34830487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551541A Withdrawn JP2007526248A (ja) 2004-01-27 2005-01-27 胃腸増殖因子およびその使用方法

Country Status (14)

Country Link
US (4) US20050256036A1 (enExample)
EP (1) EP1727560B1 (enExample)
JP (1) JP2007526248A (enExample)
KR (1) KR20070007289A (enExample)
AU (1) AU2005208945A1 (enExample)
BR (1) BRPI0507168A (enExample)
CA (1) CA2554403A1 (enExample)
IL (1) IL177060A0 (enExample)
MX (1) MXPA06008495A (enExample)
NO (1) NO20063522L (enExample)
RU (2) RU2343158C2 (enExample)
SG (1) SG149059A1 (enExample)
TW (1) TW200536859A (enExample)
WO (1) WO2005072419A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1673475B1 (en) * 2003-10-10 2010-04-28 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
US20190330295A1 (en) * 2005-05-04 2019-10-31 Zealand Pharma A/S Glucagon-like-peptide-2 (glp-2) analogues
EP1942926A4 (en) * 2005-10-07 2010-06-16 Nuvelo Inc STEM CELL FACTOR ARTIFICIAL PROTEIN SCFA1 AND ITS USES
EP2094836B1 (en) 2006-11-15 2016-06-08 Massachusetts Eye & Ear Infirmary Generation of inner ear cells
WO2008088524A2 (en) * 2006-12-28 2008-07-24 Nuvelo, Inc. Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
EP3009148B1 (en) 2007-07-02 2018-08-22 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
US9464275B2 (en) 2008-08-21 2016-10-11 The Board Of Trustees Of The Leland Stanford Junior University Ex vivo culture, proliferation and expansion of intestinal epithelium
CA2743436C (en) * 2008-11-24 2017-10-31 Massachusetts Eye & Ear Infirmary Pathways to generate hair cells
PL3441458T3 (pl) 2009-02-03 2023-11-06 Koninklijke Nederlandse Akademie Van Wetenschappen Podłoże do hodowli nabłonkowych komórek macierzystych i organoidów zawierających wspomniane komórki macierzyste
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
RU2532323C2 (ru) * 2011-06-20 2014-11-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения патологического синдрома и способ лечения функциональных нарушений кишечника
GB201106395D0 (en) * 2011-04-14 2011-06-01 Hubrecht Inst Compounds
EP3401329A1 (en) 2011-07-15 2018-11-14 OncoMed Pharmaceuticals, Inc. Rspo binding agents and uses thereof
JP6335896B2 (ja) 2012-07-13 2018-05-30 オンコメッド ファーマシューティカルズ インコーポレイテッド Rspo3結合剤およびその使用法
HK1211875A1 (en) 2012-09-07 2016-06-03 Massachusetts Eye & Ear Infirmary Treating hearing loss
US10047134B2 (en) * 2013-01-10 2018-08-14 Biocon Limited Process for expression of recombinant proteins in Pichia pastoris using a fed batch model
WO2016022776A2 (en) 2014-08-06 2016-02-11 Massachusetts Eye And Ear Infirmary Increasing atoh1 life to drive sensorineural hair cell differentiantion
CA2961374A1 (en) 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
CA3009153A1 (en) 2015-01-30 2016-08-04 The University Of North Carolina At Chapel Hill Methods to generate gastrointestinal epithelial tissue constructs
US11185536B2 (en) 2015-12-04 2021-11-30 Massachusetts Eye And Ear Infirmary Treatment of hearing loss by inhibition of casein kinase 1
CN109219439B (zh) 2016-01-29 2022-09-20 马萨诸塞眼科耳科诊所 内耳支持细胞的扩增和分化及其使用方法
US11180735B2 (en) 2016-10-28 2021-11-23 The Board Of Trustees Of The Leland Stanford Junior University Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof
DK3881861T3 (da) 2017-06-16 2024-09-09 Zealand Pharma As Doseringsregimer for indgivelse af glukagonlignende peptid-2- (GLP-2)-analoger
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures
JP7371012B2 (ja) 2018-05-15 2023-10-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル インビトロ細胞培養の為の自己持続型の低酸素状態並びにガス勾配及び非ガス化学勾配を生成するデバイス、システム、及び装置
EP3802848A4 (en) 2018-05-25 2022-03-09 The University of North Carolina at Chapel Hill FORMATION OF ARRAYS OF PLANAR INTESTINAL CRYPTS WITH A STEM CELL/PROLIFERATIVE CELL COMPARTMENT AND A DIFFERENTIATED CELL ZONE
WO2020102682A1 (en) 2018-11-16 2020-05-22 The University Of North Carolina At Chapel Hill In vitro cell culture mucus systems
WO2021247497A1 (en) * 2020-06-03 2021-12-09 Children's Hospital Medical Center Compositions and methods comprising r-spondins for treatment of tumors
CA3219754A1 (en) 2021-05-21 2022-11-24 Gary Beale Microwave treatment of tissue
US12465781B2 (en) 2021-06-11 2025-11-11 Joon Bu Park Negative Poisson's ratio materials for thermal and radiation therapy seeds
WO2023097236A1 (en) * 2021-11-24 2023-06-01 The Rockefeller University Compositions and methods for generating immunoglobulin knock-in mice

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2198180C2 (ru) * 1994-10-13 2003-02-10 Амген Инк. Аналог природного фактора роста кератиноцитов (варианты), фармацевтическая композиция, рекомбинантная молекула нуклеиновой кислоты, кодирующая аналог, экспрессионный вектор, штамм e.coli, трансформированный вектором, способ получения аналога и способ стимулирования образования нефибробластных эпителиальных клеток
US6824973B2 (en) * 2000-02-03 2004-11-30 Kirin Beer Kabushiki Kaisha Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
CA2405104A1 (en) 2000-04-05 2001-10-18 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US20030032034A1 (en) * 2001-03-05 2003-02-13 Tang Y. Tom Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US7411052B2 (en) * 2001-03-05 2008-08-12 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
ATE553193T1 (de) * 2001-08-30 2012-04-15 Arca Biopharma Inc Verfahren und materialien in verbindung mit stammzellen-wachstumsfaktor-ähnlichen polypeptiden und polynukleotiden
CA2462795A1 (en) 2001-10-03 2003-04-10 Incyte Genomics, Inc. Secreted proteins
CA2469941A1 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
WO2005110009A2 (en) 2003-07-22 2005-11-24 Immunex Corporation COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
US20050169995A1 (en) * 2003-10-03 2005-08-04 Kuo Calvin J. Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
EP1673475B1 (en) * 2003-10-10 2010-04-28 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt

Similar Documents

Publication Publication Date Title
JP2007526248A5 (enExample)
JPWO2019107530A5 (enExample)
JP2007515393A5 (enExample)
JP2011528333A5 (enExample)
JP2011225596A5 (enExample)
JP2006507270A5 (enExample)
RU2006130791A (ru) Желудочно-кишечный пролиферативный фактор и его применения
JP2011528895A5 (enExample)
JP2014530220A5 (enExample)
JP2018519366A5 (enExample)
MA32539B1 (fr) Traitement du diabète chez des patients pour lesquels une thérapie par la metformine n'est pas appropriée
JP2008536483A5 (enExample)
JP2014513952A5 (enExample)
WO2011156453A3 (en) Therapeutic peptides
JP2010501596A5 (enExample)
JP2006506942A5 (enExample)
JP2013510169A5 (enExample)
JP2009501801A5 (enExample)
JP2018048151A5 (enExample)
JP2017221201A5 (enExample)
JP2010536714A5 (enExample)
JP2011528334A5 (enExample)
JP2010512326A5 (enExample)
JP2020117504A5 (enExample)
JP2016515123A5 (enExample)